New proposal for the staging of nonalcoholic steatohepatitis: Evaluation of liver fibrosis on Gd-EOB-DTPA-enhanced MRI

Tokushige, 2007, Influence of TNF gene polymorphisms in Japanese patients with NASH and simple steatosis, J Hepatol, 10.1016/j.jhep.2007.01.028 Yamazaki, 2007, The role of the nuclear receptor constitutive androstane receptor in the pathogenesis of non-alcoholic steatohepatitis, Gut, 56, 565, 10.1136/gut.2006.093260 Iacobellis, 2006, Non invasive evaluation of liver fibrosis in paediatric patients with nonalcoholic steatohepatitis, World J Gastroenterol, 12, 7821, 10.3748/wjg.v12.i48.7821 Otogawa, 2007, Erythrophagocytosis by liver macrophages (Kupffer cells) promotes oxidative stress, inflammation, and fibrosis in a rabbit model of steatohepatitis, Am J Pathol, 170, 967, 10.2353/ajpath.2007.060441 Miele, 2007, Noninvasive assessment of fibrosis in non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH), Transl Res, 149, 114, 10.1016/j.trsl.2006.11.011 Nakayama, 2007, Transgenic mice expressing nuclear sterol regulatory element-binding protein 1c in adipose tissue exhibit liver histology similar to nonalcoholic steatohepatitis, Metabolism, 56, 470, 10.1016/j.metabol.2006.11.004 Ito, 2006, Development of nonalcoholic steatohepatitis model through combination of high-fat diet and tetracycline with morbid obesity in mice, Hepatol Res, 34, 92, 10.1016/j.hepres.2005.12.001 Ikejima, 2005, The role of leptin in progression of non-alcoholic fatty liver disease, Hepatol Res, 33, 151, 10.1016/j.hepres.2005.09.024 Tsuda, 2007, Potential of gadolinium-ethoxybenzyl-diethylenetriamine pentaacetic acid (Gd-EOB-DTPA) for differential diagnosis of nonalcoholic steatohepatitis and fatty liver in rats using magnetic resonance imaging, Invest Radiol, 42, 242, 10.1097/01.rli.0000258058.44876.a5 Halavaara, 2006, Liver Tumor characterization: comparison between liver-specific gadoxetic acid disodium-enhanced MRI and biphasic CT-amulticenter trial, J Comput Assist Tomogr, 30, 345, 10.1097/00004728-200605000-00001 Jung, 2006, Imaging characteristics of hepatocellular carcinoma using the hepatobiliary contrast agent Gd-EOB-DTPA, Acta Radiol, 47, 15, 10.1080/02841850500406795 Bluemke, 2005, Efficacy and safety of MR imaging with liver-specific contrast agent: U.S. multicenter phase III study, Radiology, 237, 89, 10.1148/radiol.2371031842 Saito, 2005, Gd-EOB-DTPA enhanced MRI for hepatocellular carcinoma: quantitative evaluation of tumor enhancement in hepatobiliary phase, Magn Reson Med Sci, 4, 1, 10.2463/mrms.4.1 Schuhmann-Giampieri, 1992, Preclinical evaluation of Gd-EOB-DTPA as a contrast agent in MR imaging of the hepatobiliary system, Radiology, 183, 59, 10.1148/radiology.183.1.1549695 Klumpp, 2006, Assessment of myocardial viability using delayed enhancement magnetic resonance imaging at 3.0 tesla, Invest Radiol, 41, 661, 10.1097/01.rli.0000233321.82194.09 Uhl, 2005, Osteosarcoma: preliminary results of in vivo assessment of tumor necrosis after chemotherapy with diffusion- and perfusion-weighted magnetic resonance imaging, Invest Radiol, 41, 618, 10.1097/01.rli.0000225398.17315.68 Knopp, 2006, Assessment of utilization and pharmacovigilance based on spontaneous adverse event reporting of gadopentetate dimeglumine as a magnetic resonance contrast agent after 45 million administrations and 15 years of clinical use, Invest Radiol, 41, 491, 10.1097/01.rli.0000209657.16115.42 Kawaguchi, 2004, Pioglitazone prevents hepatic steatosis, fibrosis, and enzyme-altered lesions in rat liver cirrhosis induced by a choline-deficient l-amino acid-defined diet, Biochem Biophys Res Commun, 315, 187, 10.1016/j.bbrc.2004.01.038 Sakaida, 2003, Herbal medicine Inchin-ko-to (TJ-135) prevents liver fibrosis and enzyme-altered lesions in rat liver cirrhosis induced by a choline deficient l-amino acid-defined diet, J Hepatol, 38, 762, 10.1016/S0168-8278(03)00094-1 Bergheim, 2006, Critical role of plasminogen activator inhibitor-1 in cholestatic liver injury and fibrosis, J Pharmacol Exp Ther, 316, 592, 10.1124/jpet.105.095042 Li, 2005, Morphological and serum hyaluronic acid, laminin and type IV collagen changes in dimethylnitrosamine-induced hepatic fibrosis of rats, World J Gastroenterol, 11, 7620, 10.3748/wjg.v11.i48.7620 Li, 2005, Pathological mechanisms of alcohol-induced hepatic portal hypertension in early stage fibrosis rat model, World J Gastroenterol, 11, 6483, 10.3748/wjg.v11.i41.6483 Lydatakis, 2006, Clinical studies: non-invasive markers to predict the liver fibrosis in non-alcoholic fatty liver disease, Liver Int, 26, 864, 10.1111/j.1478-3231.2006.01312.x Libra, 2006, Molecular determinants in the transport of a bile acid-derived diagnostic agent in tumoral and nontumoral cell lines of human liver, J Pharmacol Exp Ther, 319, 809, 10.1124/jpet.106.106591 van Montfoort, 1999, Hepatic uptake of the magnetic resonance imaging contrast agent gadoxetate by the organic anion transporting polypeptide Oatp1, J Pharmacol Exp Ther, 290, 153 Pascolo, 1999, Molecular mechanisms for the hepatic uptake of magnetic resonance imaging contrast agents, Biochem Biophys Res Commun, 257, 746, 10.1006/bbrc.1999.0454 Guardigli, 2005, Chemiluminescence quantitative immunohistochemical determination of MRP2 in liver biopsies, J Histochem Cytochem, 53, 1451, 10.1369/jhc.5A6621.2005 Geier, 2003, Effects of proinflammatory cytokines on rat organic anion transporters during toxic liver injury and cholestasis, Hepatology, 38, 345, 10.1053/jhep.2003.50317 Kojima, 2003, Changes in the expression and localization of hepatocellular transporters and radixin in primary biliary cirrhosis, J Hepatol, 39, 693, 10.1016/S0168-8278(03)00410-0 Geier, 2002, Hepatobiliary organic anion transporters are differentially regulated in acute toxic liver injury induced by carbon tetrachloride, J Hepatol, 37, 198, 10.1016/S0168-8278(02)00108-3